Skip to main content

Table 3 Decrease in minimum plasma glucose levels

From: Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study

Minimum plasma glucoseRepaglinide and clopidogrel groupMitiglinide and clopidogrel groupRepaglinide group
(N = 15)(N = 15)(N = 15)
Before starting glinide145.2 ± 42.9133.5 ± 33.5113.6 ± 23.5
After starting glinide93.3 ± 36.3131.4 ± 42.998.1 ± 21.8
Decrease in minimum levels51.9 ± 47.5 *2.1 ± 29.115.5 ± 20.0
  1. Mean ± S.D., * p < 0.05 for the “repaglinide and clopidogrel group” versus the “mitiglinide and clopidogrel group”, and the “repaglinide and clopidogrel group” versus the “repaglinide group”